SureTrader Stock Hero Advertisement SureTrader SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator DewDiligence
Search This Board:
Last Post: 5/24/2015 8:38:45 AM - Followers: 63 - Board type: Free - Posts Today: 1
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#1013   Methinks there are better risk/reward ratios out there WorstLuck 05/24/15 08:38:45 AM
#1012   I had planned to buy back some enta linhdtu 05/23/15 11:54:25 AM
#1011   I don't like the latest insider sale by linhdtu 05/22/15 01:42:36 PM
#1010   I mentioned I sold half at $50 when lgonber 05/20/15 12:31:27 PM
#1009   Not planning to sell anytime soon (unless I'm DewDiligence 05/20/15 11:42:00 AM
#1008   Dew, DO you have a pps target for lgonber 05/20/15 11:40:30 AM
#1007   Haven't seen them yet, but will look for DewDiligence 05/15/15 12:31:55 PM
#1006   Catch the Rx #s per chance? My friend pollyvonwog 05/15/15 12:29:39 PM
#1005   In case no one noticed: Today is first DewDiligence 05/15/15 10:58:04 AM
#1004   DB Analyst note today - target remains at guyschmid 05/12/15 09:28:53 AM
#1003   Leerink revision is $42 to $41. Tweak as guyschmid 05/11/15 08:20:26 AM
#1002   ENTA PT has been cut to $41 by lgonber 05/11/15 03:59:40 AM
#1001   The 1Q15 10-Q has been filed with an DewDiligence 05/08/15 05:15:37 PM
#1000   ENTA’s FY2Q15 press release: DewDiligence 05/07/15 01:01:10 PM
#999   Please see reply in #msg-113432107. DewDiligence 05/07/15 09:55:04 AM
#998   as $7.0 million in royalty revenue for Q1? biotech_researcher 05/07/15 09:45:22 AM
#997   Props to you for predicting this. Pretty sure DewDiligence 05/06/15 08:59:24 PM
#996   MRK might still be debating what their commercial DewDiligence 05/06/15 08:54:34 PM
#995   Any chance MRK goes the same route? ;) pollyvonwog 05/06/15 08:38:04 PM
#994   BMY confirms that it’s not an HCV competitor DewDiligence 05/06/15 11:25:43 AM
#993   425 NRx 798 TRx it looks like pollyvonwog 05/01/15 01:52:15 PM
#992   Have you seen symphony #s for the week? TIA pollyvonwog 05/01/15 09:35:25 AM
#991   ESRX 1Q15 CC: HCV (i.e. V-Pak) patients are DewDiligence 04/29/15 06:32:18 PM
#990   The DB conference is in Boston, so it’s DewDiligence 04/28/15 08:41:06 PM
#989   Busy day for Luly. Speaking at the DB pollyvonwog 04/28/15 08:15:31 PM
#988   Notes on MRK’s purported 3-DAA HCV regimen: #msg-113161246. DewDiligence 04/28/15 09:22:47 AM
#987   ENTA’s FY2Q15 CC is 5/7/15 at 8:30am ET: DewDiligence 04/27/15 09:02:57 AM
#986   EASL ABBVIE/ENTA presentation willyw 04/25/15 10:25:03 AM
#985   Thanks Rocky. Good points and agree that the pollyvonwog 04/24/15 09:38:35 AM
#984   The avg in April (2 weeks only) has Rocky3 04/24/15 08:28:17 AM
#983   FWIW since some RXs are being blocked the pollyvonwog 04/23/15 12:11:26 PM
#982   ABBV/ENTA GT4 NDA for 2-DAA Viekira regimen gets DewDiligence 04/23/15 11:41:39 AM
#981   At least it has been an orderly walk down.. biotech_researcher 04/23/15 11:32:59 AM
#980   ABBV reiterated V-Pak sales guidance for an annualized DewDiligence 04/23/15 09:32:37 AM
#979   Deutsche Bank - 6 April 2015 initiation says: guyschmid 04/23/15 09:28:44 AM
#978   V-Pak Global Sales $231 mil in Q1: steveporsche 04/23/15 08:07:20 AM
#977   Well if the consensus for Q1 is 268M$ linhdtu 04/22/15 11:23:52 PM
#976   Job ad due diligence investorhubalias 04/22/15 07:20:23 PM
#975   1Q15 consensus estimate for V-Pak is $268M, according DewDiligence 04/22/15 03:05:00 PM
#974   7:01 pm AbbVie: Investigational chronic hepatitis C treatment steveporsche 04/15/15 11:29:22 PM
#973   ABBV’s 1Q15 earnings release and CC on 4/23/15: DewDiligence 04/15/15 10:11:58 AM
#972   looking ahead it very well may be mrk dewophile 04/10/15 01:27:00 PM
#971   FWIW, I agree a duopoly. willyw 04/10/15 12:41:39 PM
#970   Another head scratcher from Bernstein: HCV mkt pollyvonwog 04/10/15 10:13:01 AM
#969   Don't be bashful now. Let us know nowlurking 04/09/15 11:04:25 AM
#968   I concur with pollyvonwag’s reply. I tweeted this yesterday: DewDiligence 04/09/15 10:59:36 AM
#967   The Citigroup analyst is out to lunch. 1) pollyvonwog 04/09/15 10:48:32 AM
#966   From Barron's writeup with regard to Citigroup analyst - nowlurking 04/09/15 10:43:35 AM
#965   MRK's C-EDGE SVR4 data are ok but nothing DewDiligence 04/08/15 09:06:45 AM
#964   Not only was the SVR4 rate 99%, but DewDiligence 04/08/15 08:51:25 AM
PostSubject